In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016

Thromb Res. 1999 Jan 1;93(1):43-50. doi: 10.1016/s0049-3848(98)00134-0.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aspirin / analogs & derivatives*
  • Aspirin / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Fibrinolytic Agents / therapeutic use*
  • Male
  • Nitric Oxide / metabolism*
  • Nitroprusside / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Rats
  • Rats, Wistar
  • Thromboxanes / biosynthesis

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Thromboxanes
  • Nitroprusside
  • Nitric Oxide
  • nitroaspirin
  • Aspirin